What is Jotec?
Headline goes here
Subheadline goes here
Jotec is a German-based privately-held medical device company founded in 2005. Jotec develops, manufactures, and markets technologically differentiated minimally invasive cardiovascular products for the treatment of aortic diseases.
Jotec's products are used in a variety of procedures, including endovascular aortic repair (EVAR), thoracic endovascular aortic repair (TEVAR), and abdominal aortic aneurysm (AAA) repair.
The company's flagship product is the E-vita Open Neo, a next-generation hybrid graft system for WEB. The E-vita Open Neo is designed to provide a minimally invasive and more effective alternative to traditional open surgery for the treatment of aortic aneurysms.
Jotec's History
Jotec was founded in 2005 by a team of experienced medical device engineers and clinicians. The company's mission is to develop and market innovative cardiovascular products that improve patient outcomes.
Jotec has a strong track record of innovation. In 2010, the company received the Frost & Sullivan Award for New Product Innovation for its E-vita Open Neo.
In 2017, Jotec was acquired by Artivion Inc., a leading medical device company. Artivion's acquisition of Jotec has allowed the company to accelerate its growth and expand its product portfolio.
Jotec's Products
Jotec's product portfolio includes a variety of minimally invasive cardiovascular products for the treatment of aortic diseases. The company's flagship product is the E-vita Open Neo, a next-generation hybrid graft system for WEB.
The E-vita Open Neo is designed to provide a minimally invasive and more effective alternative to traditional open surgery for the treatment of aortic aneurysms. The E-vita Open Neo is made from a unique combination of materials that provides both strength and flexibility.
The E-vita Open Neo is also designed to be easy to use. The system can be deployed through a small incision in the groin. This allows for a less invasive procedure with a shorter recovery time.
Jotec's Future
Jotec is a rapidly growing company with a bright future. The company's innovative products are improving patient outcomes and changing the way aortic diseases are treated.
Jotec is committed to continuing to develop new and innovative products that improve patient care. The company is also committed to expanding its global reach and making its products available to patients around the world.
Comments